Energy Fuels Reports Q1 Results with $956.6M Working Capital, Advances Uranium and Rare Earth Projects

Energy Fuels Inc. reported strong Q1 financials and operational progress, highlighting its strategic position in critical minerals production.

Dallas Metrowire Staff
Energy
Energy Fuels Reports Q1 Results with $956.6M Working Capital, Advances Uranium and Rare Earth Projects

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a U.S.-based uranium, rare earth elements (REEs) and critical minerals producer, reported its first quarter 2026 results, showcasing a robust working capital position of $956.6 million and advancing key development initiatives across its portfolio. The company generated $36 million in revenue and $8.3 million in cash from operating activities, while reducing its net loss to $10.8 million. During the quarter, Energy Fuels produced 790,000 pounds of finished U3O8, maintaining its status as the leading U.S. producer of natural uranium concentrate.

The financial strength underscores Energy Fuels' ability to fund its diversified operations, which span uranium, rare earth elements, heavy mineral sands, vanadium, and medical isotope development. The company owns the only fully licensed conventional uranium mill operating in the U.S.—the White Mesa Mill in Utah—where it also produces REE products and evaluates medical isotope recovery for emerging cancer therapies. This facility is central to the company's strategy of becoming a multi-commodity critical materials supplier.

Beyond uranium, Energy Fuels is advancing three heavy mineral sands/rare earths projects: the Vara Mada Project in Madagascar, the Bahia Project in Brazil, and the Donald Project in Australia (through a joint venture with Astron Limited). These projects are positioned to supply rare earth elements essential for clean energy technologies, electronics, and defense applications. The company's progress in REEs is particularly significant given the global push to diversify supply chains away from dominant foreign producers.

The Q1 results also highlight Energy Fuels' commitment to medical isotope development, targeting the production of isotopes used in cancer treatments. This initiative leverages the company's existing infrastructure and expertise in radioactive materials processing. The company's working capital of $956.6 million provides a strong foundation for these growth initiatives without immediate financing concerns.

Energy Fuels' performance and strategic direction are closely watched by investors and industry observers, as the company sits at the intersection of nuclear energy resurgence and the critical minerals race. With uranium prices supported by growing demand for carbon-free baseload power and REE demand driven by electrification and defense needs, Energy Fuels is well-positioned to benefit from these long-term trends. For more details, the full press release can be accessed at https://ibn.fm/r07Hd. Additional updates on the company are available in its newsroom at http://ibn.fm/UUUU.

Blockchain Registration

QR Code for Blockchain Registration